Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease
NCT05012631Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Sep 2021
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of losartan in myocardial fibrosis, sponsored by Cincinnati Children's Hospital Medical Center. Started Sep 2021; status: completed.
02
Drugs
losartan
03
Conditions
myocardial fibrosis
Beyond the preview
Go deeper on NCT05012631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05012631.